52 related articles for article (PubMed ID: 11135013)
21. Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.
Castañé A; Robledo P; Matifas A; Kieffer BL; Maldonado R
Eur J Neurosci; 2003 Jan; 17(1):155-9. PubMed ID: 12534979
[TBL] [Abstract][Full Text] [Related]
22. Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
Gavériaux-Ruff C; Matthes HW; Peluso J; Kieffer BL
Proc Natl Acad Sci U S A; 1998 May; 95(11):6326-30. PubMed ID: 9600964
[TBL] [Abstract][Full Text] [Related]
23. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice.
Hall FS; Sora I; Uhl GR
Psychopharmacology (Berl); 2001 Feb; 154(1):43-9. PubMed ID: 11292005
[TBL] [Abstract][Full Text] [Related]
24. Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice.
Contarino A; Picetti R; Matthes HW; Koob GF; Kieffer BL; Gold LH
Eur J Pharmacol; 2002 Jun; 446(1-3):103-9. PubMed ID: 12098591
[TBL] [Abstract][Full Text] [Related]
25. Mu opioid receptors on vGluT2-expressing glutamatergic neurons modulate opioid reward.
Reeves KC; Kube MJ; Grecco GG; Fritz BM; Muñoz B; Yin F; Gao Y; Haggerty DL; Hoffman HJ; Atwood BK
Addict Biol; 2021 May; 26(3):e12942. PubMed ID: 32686251
[TBL] [Abstract][Full Text] [Related]
26. Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene".
Tabarin A; Diz-Chaves Y; Carmona Mdel C; Catargi B; Zorrilla EP; Roberts AJ; Coscina DV; Rousset S; Redonnet A; Parker GC; Inoue K; Ricquier D; Pénicaud L; Kieffer BL; Koob GF
Diabetes; 2005 Dec; 54(12):3510-6. PubMed ID: 16306369
[TBL] [Abstract][Full Text] [Related]
27. Antidiarrheal effect of deltorphin II, a highly selective delta opioid receptor agonist, in the rat.
Broccardo M; Improta G
Pharmacol Res; 1992; 25 Suppl 1():5-6. PubMed ID: 1508807
[No Abstract] [Full Text] [Related]
28. Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain.
Cahill CM; Holdridge SV; Liu SS; Xue L; Magnussen C; Ong E; Grenier P; Sutherland A; Olmstead MC
J Neurosci Res; 2022 Jan; 100(1):129-148. PubMed ID: 32623788
[TBL] [Abstract][Full Text] [Related]
29.
Khroyan TV; Cippitelli A; Toll N; Lawson JA; Crossman W; Polgar WE; Toll L
Front Psychiatry; 2017; 8():52. PubMed ID: 28446883
[TBL] [Abstract][Full Text] [Related]
30. Molecular Pharmacology of δ-Opioid Receptors.
Gendron L; Cahill CM; von Zastrow M; Schiller PW; Pineyro G
Pharmacol Rev; 2016 Jul; 68(3):631-700. PubMed ID: 27343248
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.
Váradi A; Marrone GF; Eans SO; Ganno ML; Subrath JJ; Le Rouzic V; Hunkele A; Pasternak GW; McLaughlin JP; Majumdar S
ACS Chem Neurosci; 2015 Nov; 6(11):1813-24. PubMed ID: 26325040
[TBL] [Abstract][Full Text] [Related]
32. Advancing addiction treatment: what can we learn from animal studies?
Wu PH; Schulz KM
ILAR J; 2012; 53(1):4-13. PubMed ID: 23520595
[TBL] [Abstract][Full Text] [Related]
33. Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor.
Le Merrer J; Rezai X; Scherrer G; Becker JA; Kieffer BL
Neuropsychopharmacology; 2013 May; 38(6):1050-9. PubMed ID: 23303070
[TBL] [Abstract][Full Text] [Related]
34. Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors.
Le Merrer J; Faget L; Matifas A; Kieffer BL
Psychopharmacology (Berl); 2012 Sep; 223(1):99-106. PubMed ID: 22526530
[TBL] [Abstract][Full Text] [Related]
35. [The endogenous opioid system and drug addiction].
Maldonado R
Ann Pharm Fr; 2010 Jan; 68(1):3-11. PubMed ID: 20176158
[TBL] [Abstract][Full Text] [Related]
36. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
Berrendero F; Robledo P; Trigo JM; Martín-García E; Maldonado R
Neurosci Biobehav Rev; 2010 Nov; 35(2):220-31. PubMed ID: 20170672
[TBL] [Abstract][Full Text] [Related]
37. Genetics of tobacco use.
Maserejian NN; Zavras AI
Tob Induc Dis; 2004 Jun; 2(2):81-102. PubMed ID: 19570274
[TBL] [Abstract][Full Text] [Related]
38. Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.
Archer-Lahlou E; Audet N; Amraei MG; Huard K; Paquin-Gobeil M; Pineyro G
J Cell Mol Med; 2009 Jan; 13(1):147-63. PubMed ID: 18363847
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
Berrendero F; Kieffer BL; Maldonado R
J Neurosci; 2002 Dec; 22(24):10935-40. PubMed ID: 12486188
[TBL] [Abstract][Full Text] [Related]
40. Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice.
Hutcheson DM; Matthes HW; Valjent E; Sánchez-Blázquez P; Rodríguez-Díaz M; Garzón J; Kieffer BL; Maldonado R
Eur J Neurosci; 2001 Jan; 13(1):153-61. PubMed ID: 11135013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
